| |
| |
|
| Insider
Information: |
Del Carmen Jeffrey |
| Relationship: |
Chief Commercial Officer |
| City: |
Coral Gables |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
25,968 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$386,664 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
25,968 |
|
|
| Total
Value |
$386,664 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Catalyst Pharmaceutical Partners... |
CPRX |
Chief Commercial Officer |
2024-02-15 |
25,968 |
2021-06-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2024-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,125) |
25,968 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2024-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,667 |
29,093 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2023-12-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,839) |
18,426 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2023-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,666 |
22,265 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2023-06-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,942) |
13,599 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2023-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
17,541 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2023-03-29 |
4 |
S |
$16.69 |
$667,810 |
D/D |
(40,000) |
7,541 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2023-03-29 |
4 |
OE |
$2.24 |
$127,063 |
D/D |
40,000 |
26,558 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2023-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,125) |
7,541 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,666 |
10,666 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2022-11-11 |
4 |
S |
$15.46 |
$2,241,382 |
D/D |
(139,017) |
0 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2022-11-11 |
4 |
OE |
$2.24 |
$385,798 |
D/D |
139,017 |
19,017 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2022-08-19 |
4 |
S |
$14.05 |
$198,667 |
D/D |
(14,140) |
0 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2022-06-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,930) |
14,140 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2022-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
17,070 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2021-06-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,930) |
7,070 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Commercial Officer |
• – – |
2021-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
